The present invention relates to CCR-9 antagonists, pharmaceutical compositions containing them and their use.
本发明涉及 CCR-9 拮抗剂、含有 CCR-9 拮抗剂的药物组合物及其用途。
US7319111B2
申请人:——
公开号:US7319111B2
公开(公告)日:2008-01-15
[EN] PHENYLENEDIAMINE UROTENSIN-II RECEPTOR ANTAGONISTS AND CCR-9 ANTAGONISTS<br/>[FR] ANTAGONISTES DU RECEPTEUR DE L'UROTENSINE-II DE LA PHENYLENEDIAMINE ET ANTAGONISTES DU CCR-9
申请人:ENCYSIVE PHARMACEUTICALS INC
公开号:WO2004073634A2
公开(公告)日:2004-09-02
The present invention relates to urotensin II receptor antagonists, CCR-9 antagonists, pharmaceutical compositions containing them and their use.